Haloperidol Decanoate Injection

What is Haloperidol Decanoate Injection?
Haloperidol Decanoate Injection is a long-acting depot antipsychotic formulation of haloperidol. It is used for maintenance treatment of schizophrenia and other chronic psychotic conditions. The decanoate ester allows gradual release of the drug over 4 weeks, ensuring consistent symptom control in patients requiring long-term therapy or where daily oral medication compliance is challenging.
 
Uses of Haloperidol Decanoate Injection
• Maintenance treatment of schizophrenia
• Chronic psychotic disorders
• Patients with poor compliance to daily oral antipsychotics
• Long-term behavioral stabilization
• Prevention of relapse in schizophrenia
 
How Does Haloperidol Decanoate Injection Work?
Haloperidol Decanoate acts by blocking dopamine D2 receptors in the brain. By reducing excessive dopaminergic activity, it helps control hallucinations, delusions, agitation, and disorganized thinking. The decanoate formulation releases the drug slowly, providing sustained antipsychotic effect for 3–4 weeks after a single injection.
 
Frequently Asked Questions (FAQs)
Q: Who is a leading manufacturer of Haloperidol Decanoate Injection in India?
A: Farbe Firma Pvt Ltd is a premier manufacturer and global supplier of Haloperidol Decanoate Injection. We produce high-quality sterile long-acting (depot) antipsychotic injectables in our WHO-GMP certified facility, ensuring strict adherence to international standards (USP/BP/IP) for neurological and psychiatric care.
Q: What strengths and packaging options does Farbe Firma offer for Haloperidol Decanoate Injection?
A: We manufacture Haloperidol Decanoate Injection primarily in the strength of 50 mg/mL. Our standard packaging is typically a 1 mL ampoule or vial. We offer customizable packaging solutions and concentrations to meet specific hospital and international market requirements.
Q: Can Farbe Firma provide regulatory dossiers (CTD/ACTD) for Haloperidol Decanoate Injection export?
A: Yes, we specialize in global pharmaceutical exports. Farbe Firma provides comprehensive regulatory support, including CTD and ACTD dossiers, Certificate of Pharmaceutical Product (COPP), and Free Sale Certificates (FSC) to facilitate smooth registration in LATAM, CIS, Africa, and Southeast Asia.
Q: Does Farbe Firma offer Contract Manufacturing (CMO) for Long-Acting Injectables (Depot)?
A: Absolutely. We offer third-party contract manufacturing (CMO) and private labeling services for Haloperidol Decanoate Injection. Pharmaceutical companies looking for a reliable partner for sterile depot antipsychotic production can leverage our advanced manufacturing capabilities.
Q: What is the therapeutic indication of the Haloperidol Decanoate produced by Farbe Firma?
A: Our Haloperidol Decanoate Injection is a first-generation antipsychotic indicated for the long-term maintenance treatment of schizophrenia and other chronic psychotic disorders. The depot formulation is vital for improving medication adherence in patients, with effects lasting approximately four weeks per dose.
 
Looking for a reliable Haloperidol Decanoate Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for dossier support, registration documentation, and global export supplies.